Murtaza Akhter

Murtaza Akhter

Auto-generated profile, based on publicly available information

Murtaza Akhter

Penn State Hershey Medical Center, Hershey, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2023 in Academic Emergency Medicine
Verified
Journal Article
Closed access
JEJonathan A Edlow
Jonathan A Edlow
CCChristopher Carpenter
Christopher Carpenter
MAMurtaza Akhter
Murtaza Akhter
DKDanya Khoujah
Danya Khoujah
EMEvie Marcolini
Evie Marcolini
FBFernanda Bellolio
Fernanda Bellolio

11 February 2019 in Seminars in Neurology
Verified
Journal Article
Closed access
PDF file
LFLevi Filler
Levi Filler
PNPerrin Nimlos
Perrin Nimlos
MAMurtaza Akhter
Murtaza Akhter
The acute headache in the emergency department (ED) poses a diagnostic dilemma that may overwhelm providers attempting to weigh the cost of advanced workups against the risk of missing serious pathology. While the majority of headache concerns are benign primary headache disorders, identifying life-threatening secondary causes of headache—which may be broadly categorized into structural, infectious, and vascular causes—is the primary focus of evaluation in the ED. Secondary headaches are associated with a high morbidity and mortality, and require strict scrutiny of the history and physical examination to adequately risk-stratify patients. Innovative and emerging technologies may further assist providers in the diagnosis of headache, and challenge previous gold-standard diagnostic evaluations. Herein, we present a general overview of the workup and management of headaches in the ED, with a special section for diagnostic considerations in evaluating for acute meningitis, subarachnoid hemorrhage, and acute angle-closure glaucoma.

30 April 2018 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MAMurtaza Akhter
Murtaza Akhter
JKJeffrey Kline
Jeffrey Kline
BBBikash Bhattarai
Bikash Bhattarai
MCMark Courtney
Mark Courtney
CKChristopher Kabrhel
Christopher Kabrhel
Introduction: The American College of Emergency Physicians guidelines recommend more aggressive workup beyond imaging alone in patients with a high pretest probability (PTP) of pulmonary embolism (PE). However, the ability of multiple tests to safely rule out PE in high PTP patients is not known. We sought to measure the ability of negative computed tomography pulmonary angiography (CTPA) along with negative D-dimer to rule out PE in these high-risk patients.Methods: We analyzed data from a previous prospective observational study conducted in 12 emergency departments (ED). Wells score criteria were entered by providers before final PE testing. PE was diagnosed by imaging on the index ED visit, or within 45 days, demonstrating either PE ordeep vein thrombosis (DVT), or if the patient died of PE during the 45-day, follow-up period. Testing threshold was set at 1.8%.Results: A total of 7,940 patients were enrolled and tested for PE, and 257 had high PTP (Wells >6). Sixteen of these high-risk patients had negative CTPA and negative D-dimer, of whom two were positive for PE (12.5% [95% confidence interval 2.2%-40.0%]). One of these patients had a DVT on CT venogram and the other was diagnosed at follow-up.Conclusion: Our analysis suggests that in patients with high PTP of PE, neither negative CTPA by itself nor a negative CTPA plus a negative D-dimer are sufficient to rule out PE. More aggressive workup strategies may be required for these patients.

1 June 2018 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
MAMurtaza Akhter
Murtaza Akhter
JKJeffrey Kline
Jeffrey Kline
VKVijay Kannan
Vijay Kannan
DCD. Mark Courtney
D. Mark Courtney
CKChristopher Kabrhel
Christopher Kabrhel

1 May 2018 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
MAMurtaza Akhter
Murtaza Akhter
TQTom Qin
Tom Qin
PFPaul Fischer
Paul Fischer
HSHoma Sadeghian
Homa Sadeghian
HKHyung Hwan Kim
Hyung Hwan Kim
CACenk Ayata
Cenk Ayata
Rho‐associated kinase (ROCK) is an emerging target in acute ischemic stroke. Early pre‐hospital treatment with ROCK inhibitors may improve their efficacy, but their antithrombotic effects raise safety concerns in hemorrhagic stroke, precluding use prior to neuroimaging. Therefore, we tested whether ROCK inhibition affects the bleeding times, and worsens hematoma volume in a model of intracerebral hemorrhage (ICH) induced by intrastriatal collagenase injection in mice. Tail bleeding time was measured 1 h after treatment with isoform‐nonselective inhibitor fasudil, or ROCK2‐selective inhibitor KD025, or their vehicles. In the ICH model, treatments were administered 1 h after collagenase injection. Although KD025 but not fasudil prolonged the tail bleeding times, neither drug expanded the volume of ICH or worsened neurological deficits at 48 h compared with vehicle. Although more testing is needed in aged animals and comorbid models such as diabetes, these results suggest ROCK inhibitors may be safe for pre‐hospital administration in acute stroke.

1 April 2018 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MAMurtaza Akhter
Murtaza Akhter
Human health has improved dramatically over the last couple centuries.1 Yet, disparities remain, and recent work2 suggests that these disparities are widening for life expectancy. These disparities are owing to a combination of socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health care factors. However, multivariable analyses that include all these risk factors suggest that the variations in life expectancy are largely explained by behavioral and metabolic risk factors, with socioeconomic and race/ethnicity factors no longer being statistically significant.2 This is an interesting finding, especially given how much we hear about rising income inequality.3 Indeed, in bivariate analysis, income is the strongest predictor of life expectancy.2 Given these somewhat incongruous results, I sought to compare the rise of income inequality, as well as racial inequality, over the same time frame as the rise in life expectancy inequality.